Exhibit D 25Feb25.docx

This is a pricing exhibit (Exhibit D) detailing radiopharmaceutical products and quantities required for Naval Medical Center Portsmouth from April 1, 2028 to March 31, 2029. The exhibit lists specific radiopharmaceuticals including various Technetium-99m compounds, Iodine-123, Iodine-131, Fluorine-18, Copper-64, and Gallium-68 products with their respective dosage units and maximum annual quantities. Key items include 400 doses of Tc-99m Tetrofosmin for cardiac imaging, 450 doses of F-18 FDG for PET scans, and 60 doses of Ga-68 Gozetotide.

The document is part of solicitation HT940625R0004, a Firm Fixed Price IDIQ contract for General Nuclear Medicine Radiopharmaceuticals being procured by the Defense Health Agency. The exhibit also includes service charges for deliveries (with first 3 weekday deliveries free), after-hours delivery charges, and software license support fees. Vendors must submit proposals following guidelines in the SF1449 form, and the procurement will be conducted under FAR Part 12 and 13 for commercial items using simplified acquisition procedures.